RANDOMIZED STUDY OF STEREOTACTIC BODY RADIATION THERAPY (SBRT) VERSUS TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELLUAR CARCINOMA

Primary Sponsor

Trial Contact

qa@trog.com.au

Related Post

HeSANDA database for clinical trial data
21 April, 2025

Trial data-sharing made easier with HeSANDA initiative

Latest News: 21 April 2025 TROG Cancer Research is

SMART trial grant
16 April, 2025

Mark Hughes Foundation grant for innovative SMART trial into brain metastases

LATEST NEWS: 15 April 2025 An innovative trial aimed